← All trials
NCT06698744
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 25, 2025
- Primary completion
- Dec 11, 2026
- Completion date
- Sep 30, 2028
- First posted
- Nov 21, 2024
- Last posted
- Nov 21, 2024
- Enrollment
- 12
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Case Western Reserve UniversityLead sponsor
- Case Western Reserve UniversityOfficial
- Case Western Reserve UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.